Homepage | CIDRAP
Patients receiving 6 weeks of oral versus IV antibiotics had similar reoperation and reinfection rates, but primary and secondary analyses differed on noninferiority.
About CIDRAP | CIDRAP
Real-world infectious disease experts The Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to prevent illness and death from targeted infectious disease ...
CWD Report 2025 | CIDRAP
The report provides useful guidance to professionals at human, animal, and wildlife health agencies; academic researchers; and medical practitioners who will be tasked with responding to any human or non-cervid animal chronic wasting disease spillover.
Infectious Disease Topics A-Z - CIDRAP
A comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
COVID-19 | CIDRAP
Public health professionals use some terms imprecisely, others incorrectly, and still others technically accurate but almost sure to be misunderstood by the public.
CIDRAP report highlights gaps, offers guidance for possible CWD ...
Jan 8, 2025 · The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota today published a comprehensive, state-of-the-art report aimed at improving surveillance, research, and response to a potential chronic wasting disease (CWD) spillover from cervids such as deer to people or ...
All News | CIDRAP
Patients receiving 6 weeks of oral versus IV antibiotics had similar reoperation and reinfection rates, but primary and secondary analyses differed on noninferiority. Estimated effectiveness against infection was 72% in veterans aged 80 and older and 72% in those with weakened immune systems. The 2.
Our Projects - CIDRAP
Infectious disease resources in an ever-changing world CIDRAP operates many projects intended to improve knowledge in infectious disease preparedness and response, share expertise with decision makers locally and worldwide, and serve as a resource to assist communities in our region and around the world. We are constantly assessing and adjusting these programs to align with the ever-changing ...
Episode 166: Infectious Diseases Roulette - CIDRAP
Sep 19, 2024 · In this episode, Dr. Osterholm and Chris Dall cover the latest infectious disease news on topics including H5N1, mpox, measles, and polio. Dr. Osterholm also answers an ID query on updated COVID-19 vaccines and gives his thoughts on a controversial study on Paxlovid. Evidence growing for COVID antivirals to cut poor outcomes, long COVID, experts say (CIDRAP News) The world is not ready for the ...
COVID-19: CIDRAP Commentaries
Living with COVID-19 will require some shifts in approach and new goals. No one knows what the future will hold, but now is the time to improve vaccine acceptance, vaccine technology, therapeutics (drugs), ventilation, surveillance, reporting, testing quality, and testing capacity. We need global investment. We need to focus on equity. These approaches are fundamental to dealing with future ...